Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABALOPARATIDE Cause Incorrect dose administered by device? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Incorrect dose administered by device have been filed in association with ABALOPARATIDE (Tymlos). This represents 0.1% of all adverse event reports for ABALOPARATIDE.

18
Reports of Incorrect dose administered by device with ABALOPARATIDE
0.1%
of all ABALOPARATIDE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Incorrect dose administered by device From ABALOPARATIDE?

Of the 18 reports, 1 (5.6%) required hospitalization.

Is Incorrect dose administered by device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABALOPARATIDE. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does ABALOPARATIDE Cause?

Headache (4,048) Nausea (3,134) Dizziness (3,005) Fatigue (2,637) Heart rate increased (2,092) Palpitations (1,730) Arthralgia (1,711) Bone pain (1,360) Back pain (1,229) Pain (1,191)

What Other Drugs Cause Incorrect dose administered by device?

EXENATIDE (3,332) EVOLOCUMAB (2,840) SOMATROPIN (2,486) ALBUTEROL (1,236) ETANERCEPT (1,032) SECUKINUMAB (996) ERENUMAB-AOOE (973) BUDESONIDE\FORMOTEROL (753) INSULIN GLARGINE (753) BUDESONIDE\FORMOTEROL\GLYCOPYRROLATE (674)

Which ABALOPARATIDE Alternatives Have Lower Incorrect dose administered by device Risk?

ABALOPARATIDE vs ABATACEPT ABALOPARATIDE vs ABATACEPT SUBQ /ML ABALOPARATIDE vs ABCIXIMAB ABALOPARATIDE vs ABEMACICLIB ABALOPARATIDE vs ABILIFY

Related Pages

ABALOPARATIDE Full Profile All Incorrect dose administered by device Reports All Drugs Causing Incorrect dose administered by device ABALOPARATIDE Demographics